VIDEO: Chip Lavie, MD on ACE Inhibitors and ARBs in Hypertensive COVID-19 Patients

DocWire News interviews Carl J. “Chip” Lavie, MD, of the John Ochsner Heart and Vascular Institute in New Orleans, about a newly published review in the Mayo Clinic Proceedings looking at the use of angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors in hypertensive patients who also have diagnosed COVID-19.

To read the DocWire News article covering the study, click here.

To read the paper, click here.